![Donne per le Donne 2021: l'OncoImmunologia nella lotta ai tumori femminili - Fondazione Ricerca Molinette Donne per le Donne 2021: l'OncoImmunologia nella lotta ai tumori femminili - Fondazione Ricerca Molinette](https://fondazionericercamolinette.it/wp-content/uploads/2021/05/Gruppo-OncoImmunologia-1-scaled.jpg)
Donne per le Donne 2021: l'OncoImmunologia nella lotta ai tumori femminili - Fondazione Ricerca Molinette
![Donne per le Donne 2021: l'OncoImmunologia nella lotta ai tumori femminili - Fondazione Ricerca Molinette Donne per le Donne 2021: l'OncoImmunologia nella lotta ai tumori femminili - Fondazione Ricerca Molinette](https://fondazionericercamolinette.it/wp-content/uploads/2021/11/17A1323-scaled.jpg)
Donne per le Donne 2021: l'OncoImmunologia nella lotta ai tumori femminili - Fondazione Ricerca Molinette
Federica Cavallo, Ph. D. Full Professor of Immunology Department of Molecular Biotechnology and Health Sciences Molecular Biotec
![A paper from the group of Federica Cavallo shows that maternal immunization against Her2/neu oncoantigen can hamper mammary carcinogenesis in cancer-prone offspring. | Molecular Biotechnology Center A paper from the group of Federica Cavallo shows that maternal immunization against Her2/neu oncoantigen can hamper mammary carcinogenesis in cancer-prone offspring. | Molecular Biotechnology Center](https://www.mbc.unito.it/sites/x027/files/contenuto_generico/immagini/balutello.jpg)
A paper from the group of Federica Cavallo shows that maternal immunization against Her2/neu oncoantigen can hamper mammary carcinogenesis in cancer-prone offspring. | Molecular Biotechnology Center
![A paper from Federica Cavallo's group shows that immunotargeting of breast cancer stem-like cells can sensitize them to chemotherapy, offering an effective strategy to overcome drug resistance and limit metastatic progression A paper from Federica Cavallo's group shows that immunotargeting of breast cancer stem-like cells can sensitize them to chemotherapy, offering an effective strategy to overcome drug resistance and limit metastatic progression](https://www.mbc.unito.it/sites/x027/files/contenuto_generico/immagini/f_cavallo_group.jpg)
A paper from Federica Cavallo's group shows that immunotargeting of breast cancer stem-like cells can sensitize them to chemotherapy, offering an effective strategy to overcome drug resistance and limit metastatic progression
![Federica CAVALLO | PhD | Masters degree in Business Management, University of Salento (Lecce) | Università del Salento, Lecce | Unisalento | Department of Economic Sciences Federica CAVALLO | PhD | Masters degree in Business Management, University of Salento (Lecce) | Università del Salento, Lecce | Unisalento | Department of Economic Sciences](https://i1.rgstatic.net/ii/profile.image/299049690386432-1448310410347_Q512/Federica-Cavallo-4.jpg)
Federica CAVALLO | PhD | Masters degree in Business Management, University of Salento (Lecce) | Università del Salento, Lecce | Unisalento | Department of Economic Sciences
![Barack Obama on Twitter: "You can watch President Obama's second inaugural address in full here: http://t.co/6MKXqGso" / Twitter Barack Obama on Twitter: "You can watch President Obama's second inaugural address in full here: http://t.co/6MKXqGso" / Twitter](https://pbs.twimg.com/profile_images/549969365110915072/otsfS_tv_400x400.jpeg)